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Abstract
Background: The increasing number of reports of human infections by Strongyloides stercoralis from a range of
European countries over the last 20 years has spurred the interest of the scientific community towards this parasite
and, in particular, towards the role that infections of canine hosts may play in the epidemiology of human disease.
Data on the epidemiology of canine strongyloidiasis is currently limited, most likely because of the inherent limitations
of current diagnostic methods.
Methods: Faecal samples were collected directly from the rectal ampulla of 272 animals of varying age and both
genders living in Apulia, southern Italy. Dogs included were either privately owned (n = 210), living in an urban area
but with unrestricted outdoor access (Group 1), or shelter dogs (n = 62 out of ~400) hosted in a single shelter in the
province of Bari in which a history of diarrhoea, weight loss, reduced appetite and respiratory symptoms had been
reported (Group 2). Strongyloides stercoralis infection was diagnosed by coproscopy on direct faecal smear and via the
Baermann method.
Results: Six of 272 dogs were positive for S. stercoralis at the Baermann examination; all but one were from the shelter
(Group 2) and displayed gastrointestinal clinical signs. The only owned dog (Group 1) infected with S. stercoralis, but
clinically healthy, had been adopted from a shelter 1 year prior to sampling. Five infected dogs were treated with
fenbendazole (Panacur®, Intervet, Animal Health, 50 mg/kg, PO daily for 5 days), or with a combination of fenbendazole
and moxidectin plus imidacloprid spot-on (Im/Mox; Advocate® spot-on, Bayer). Post-treatment clearance of infection
was confirmed in three dogs by Baermann examination, whereas treatment failure was documented in two dogs by
Baermann and/or post-mortem detection of adult parasites.
Conclusions: This study describes, for the first time, the presence of S. stercoralis infection in sheltered dogs from
southern Italy. Data indicate that S. stercoralis infection may pose a concern for sheltered animals and raise questions
on potential risks of infection for staff of municipal shelters in southern European countries. Given that a single course
of treatment with fenbendazole, associated or not with Im/Mox spot-on, may not eliminate the infection, effective
treatment protocols should be investigated and control strategies targeting the environment considered for reducing
the risk of zoonotic infection.
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Background
Strongyloides stercoralis (Rhabditida: Strongyloididae) is
the causative agent of strongyloidiasis in a range of ver-
tebrate hosts, including humans and dogs [1], particu-
larly in tropical and subtropical areas of the world (e.g.
Africa, South America). The life-cycle of S. stercoralis is
peculiar, in that it includes sexual reproduction and
multiplication by parthenogenesis (reviewed in [2]). In
particular, adult parasitic females in the vertebrate hosts
[3] reproduce via parthenogenesis and produce both
male and female offspring. While the former will de-
velop (via moult through four larval stages) into free-
living adult nematodes, the latter develop through to
third stage-larvae (L3s), which can either complete their
development to free-living females or infect a vertebrate
host (reviewed in [2]). Importantly, the offspring derived
from the sexual reproduction of free-living males and fe-
males is inevitably parasitic [2]. Parasitic larvae mainly
penetrate the skin and mucosal tissues of vertebrate
hosts, although lactogenic transmission has also been
experimentally demonstrated in dogs [4]. Another de-
scribed route of infection (in both humans and dogs) in-
volves autoinfection by first-stage larvae (L1), which
subsequently develop through to infective L3s within the
intestinal mucosa and/or in the perianal region of the
host [5, 6].
In immunocompetent individuals, the disease is mostly
asymptomatic, whereas in immunocompromised sub-
jects the parasites can disseminate to visceral organs and
tissues, a condition known as ‘disseminated strongyloid-
iasis’ [7]. Similarly, in dogs, clinical signs of strongyloid-
iasis include asymptomatic to severe conditions,
characterized by dermatological, gastrointestinal and/or
respiratory signs, mostly in young animals [1]. Interest-
ingly, while data on the prevalence of Strongyloides in-
fections in dogs in Asia and South America are available
[8, 9]), with some areas considered endemic for this
parasite [10, 11], little is known about the presence of
this parasite in dogs in Europe, with published records
limited to single foci of infection (e.g. Germany [12],
Finland [5], Greece [13] and France [14]). However, the
increasing number of reports of human infections by S.
stercoralis recorded in a range of European countries
over the last 20 years [15] has spurred the interest of the
scientific community towards this parasite. In particular,
the role that infection of domestic dogs may play in the
epidemiology of the human disease is still under debate
[16]. Despite the increased attention, data on the epi-
demiology of canine strongyloidiasis are currently lim-
ited, most likely as a consequence of the intrinsic
limitations in the diagnostic techniques currently used
for the detection of infections in dogs. Indeed, although
serological tests (IFAT and ELISA) have been developed
for this purpose [1], detection of parasites in faecal
samples using the Baermann technique on faecal sam-
ples remains widespread. While this is often considered
the “gold standard” in clinical practice and diagnostic la-
boratories, sensitivity is limited, mainly because of the
small amount of faeces used and the intermittent shed-
ding of first-stage larvae (L1s). Therefore, multiple sam-
plings are required to unequivocally rule out the
presence of larvae in the faecal matter [6, 17].
The acquisition of data on the prevalence of infection
in canine populations in Europe is crucial to assess the
real risk of zoonotic transmission to humans. In
addition, knowledge of the range of clinical signs associ-
ated with the presence of S. stercoralis in dogs is essen-
tial in order to ensure that infection by this parasite is
inserted amongst the list of differential diagnoses in ani-
mals presented with compatible clinical signs. Given the
routes of transmission to dogs, we hypothesize that ani-
mals with unrestricted outdoor access are likely to be
continuously exposed to the infection, with dogs in shel-
ters being significantly more likely to acquire the para-
site when compared with animals kept as human
companions. However, thus far, no study has investi-
gated the difference in prevalence of S. stercoralis infec-
tion in dog cohorts coming from the same geographical
area but characterised by different lifestyles. In the
present study, we filled this gap in knowledge by investi-
gating the occurrence of canine strongyloidiasis in
owned dogs from an urban area and sheltered dogs, and
describe clinical and pathological features of the infec-
tion in six dogs along with clinical presentations and
treatment outcomes.
Methods
Study design
Faecal samples were collected directly from the rectal
ampullae of 272 animals of varying age and both genders
(see Table 1) living in Apulia, southern Italy. Dogs of all
ages and breeds were enrolled in the study; anamnestic
data including dog history, living conditions (e.g. house
or apartment with outdoor access, shelter), location,
instances of travel to other regions or abroad as well
as medical history, were collected and registered on
individual clinical forms when possible. All clinical
procedures described below were part of routine
clinical care. In particular, dogs from 2 groups were
enrolled:
Group 1: privately owned dogs (n = 210) living in an
urban area but with unrestricted outdoor access. These
dogs were presented with a variety of different clinical
conditions (including gastrointestinal signs and/or re-
spiratory signs, n = 42) or for routine clinical examina-
tions at the Clinical Unit of the Veterinary Teaching
Hospital of the University of Bari.
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Group 2: shelter dogs (n = 62) in the Province of Bari
(41°04′47″N, 16°55′17″E). In the shelter, despite an on-
going anthelmintic treatment program and controlled ali-
mentary regime, a history of diarrhoea, weight loss and
reduced appetite of unknown origin was reported in some
of the dogs over the previous years. Animals sampled were
either dogs that displayed clinical signs (n = 22) (i.e. diar-
rhoea, weight loss, reduced appetite, respiratory signs) or
healthy dogs (n = 40) located in pens in proximity of dogs
with clinical signs (see above). Animals were housed in wire
mesh cages (approximately 10 × 20 m), 4 to 7 animals per
pen, according to their gender, and existing hierarchies
within each group. The pens were made of concrete floor-
ing and were cleaned with jet water twice a day.
Diagnostic procedures
Strongyloides stercoralis infection was diagnosed by
coproscopy on direct faecal smear and/or via the Baer-
mann method [18]. Any recovered L1s were identified
according to morphological keys [19]. In case of death of
the animal (see below), necropsy was performed for para-
sitological and histopathological examination. Small por-
tions of the duodenum, jejunum and colon were
recovered and immediately scraped and washed for para-
site detection. Parasites were clarified in 20% lactophenol
and examined under the optical microscope. Adult fe-
males were processed for scanning electron microscopy
(SEM). Samples from different regions of the gut and from
all the major organs (kidneys, liver, spleen, lungs) were
collected to verify larval dissemination and fixed in 10%
buffered formalin for histopathological processing; sam-
ples were processed, embedded in paraffin, sliced at 4 μm
and stained with haematoxylin and eosin.
Clinical presentation and follow-up of positive dogs
Out of the six animals positive to S. stercoralis, five
(dogs 1–5) were presented with clinical alterations
compatible with strongyloidiasis (i.e. severe gastrointes-
tinal disease associated with hypoproteinemia). These
animals, all from Group 2, had a history of chronic dis-
ease (weight loss, diarrhoea, reduced appetite, vomiting)
except for Dog 3 that was presented with a hyper-acute
onset of depression, anorexia and vomiting that had
begun 2 days prior to sampling. One week prior to the
enrolment, the clinical conditions of Dogs 4 and 5 had
worsened, with acute vomiting and severe watery diar-
rhoea, respectively. Haematological and biochemical
analysis, including C reactive protein and serum protein
electrophoresis, were performed in all animals. Flotation
faecal test and ELISA for Giardia spp. antigens were
performed to exclude concomitant parasitic infections.
Supportive therapy was administered when needed, to-
gether with metronidazole (10 mg/kg, PO bid) to control
intestinal bacterial overgrowth in dogs with diarrhoea.
Clinical and parasitological monitoring of Strongyloides-
positive dogs was performed daily by Baermann
examination of faecal samples until the first negative
result (first follow-up), and subsequently repeated
twice a month (Table 2), on a three-day pooled faecal
sample.
Results
One privately owned dog (0.5%, 1/210; Group 1), clinic-
ally healthy, and five shelter dogs (8.1%, 5/62; Group 2)
displaying gastrointestinal clinical signs, were positive
for S. stercoralis (Table 3 ). The only owned dog (Group 1)
scoring positive had been adopted from a different shelter
1 year prior to sampling. The clinical and pathological ab-
normalities observed in the positive dogs are reported in
Table 3. All symptomatic positive dogs were thin (body
condition score- BCS 2-4) and dehydrated, except for Dog
3. Dog 1 was cachectic, highly depressed, hypothermic, se-
verely dehydrated and died within 24 h from admission.
Dog 2 showed an abnormal mass at abdominal palpation,
Table 1 Number and percentage of dogs from Groups 1 (privately owned) and 2 (shelter) enrolled in the study listed according to
gender, breed, age and occurrence of clinical signs potentially suggestive of strongyloidiasis (i.e. gastrointestinal and/or respiratory signs)
Group 1 Group 2
Total % Total %
Dogs 210 62
Gender Male 116 55 25 40
Female 94 45 37 60
Age Young < 2 yrs 46 22 13 21
Adult 2–7 yrs 81 39 27 44
Senior > 7 yrs 83 40 22 35
Breed Pure breed 84 40 0
Cross breed 126 60 62 100
Clinical status Gastrointestinal or respiratory signs 42 20 22 35
Healthy or other signs 168 80 40 65
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which was later diagnosed as type B intestinal lymphoma.
Abdominal palpation in Dog 4 evoked pain. Diarrhoea
was observed in three out of five Strongyloides-positive
dogs. Respiratory signs were not observed in any of the
dogs. The most frequent laboratory changes were mild
anemia with hypoalbuminemia (5/5) and leucocytosis,
neutrophilia, panhypoproteinemia and increased CRP (4/
5). Mild eosinophilia was observed only in one case (Dog
4). Furthermore, serum protein electrophoresis showed a
variable increase in α2- globulin fraction in all Strongy-
loides-positive dogs. For Dog 3, the diagnosis was achieved
belatedly during hospitalization, as the faecal sample col-
lected at presentation was negative. Dogs 2, 3 and 6 were
treated with fenbendazole (Panacur®, Intervet, Animal
Health, 50 mg/kg, PO daily for 5 days), whereas Dogs 4
and 5 with a combination of fenbendazole and moxidectin
plus imidacloprid spot-on (Im/Mox; Advocate® spot-on,
Bayer). No side effects were recorded following treatment
and positive dogs remained in the hospital until the end of
the monitoring period to prevent reinfection. The results
of coproscopy at follow-up are reported in Table 2. Briefly,
the first negative results were observed from 6 to 12 days
following administration of treatment, and confirmed on
three-day pooled faecal samples. Dog 3, 4 and 5 remained
negative for the parasite until the last follow-up. Dog
6 was negative at the first and only follow-up avail-
able. In Dog 2, larvae were not detected at the first
and second follow-up, while the faecal sample col-
lected at the third follow-up was again positive for
the parasite. Furthermore, this dog experienced ad-
verse reactions to the lymphoma chemotherapy proto-
col and was therefore euthanized with the consent of
the shelter manager. Dog 3 improved quickly follow-
ing fenbendazole treatment (within 1 week), whereas
Dog 4 improved slowly, reaching a normal clinical
status only at the end of the monitoring period. Des-
pite faecal consistency gradually improving following
treatment, Dog 5 died as a consequence of the severe
ongoing protein loosing enteropathy after the third
follow-up. The scraping of the intestinal mucosa of
Dog 1 (left untreated and deceased within 24 h from
admission) showed a high parasitic burden. Larval
stages were particularly abundant and L1s detected in
the faeces (200–300 μm in length) presented a typical
rhabditiform shaped esophagus and a prominent geni-
tal primordium (Fig. 1). Adult nematodes (Fig. 2),
recovered from the intestinal mucosa of the duode-
num only, were females (2.0–2.5 mm in length) pre-
senting a long cylindrical oesophagus, the vulva
located in the posterior third of the body, a narrowly
Table 3 Clinical signs and results of selected laboratory parameters at presentation (D0) in the six Strongyloides stercoralis-infected dogs
Normal range Dog 1 Dog 2 Dog 3 Dog 4 Dog 5 Dog 6
History and clinical
presentation
Long-lasting diarrhea
and weight loss;
cachexia; anorexia;
depression; hypothermia
Weight loss;
reduced
appetite;
abdominal
mass
Acute onset
of depression;
anorexia and
vomiting
Chronic weight
loss and episodic
diarrhoea; acute
vomiting and
anorexia
Chronic weight loss
and episodic diarrhoea;
severe watery diarrhoea
of 1 week duration
Adopted from
the shelter
1 year before;
healthy
WBC (k/μl) 6.00–17.00 32.6 29.9 24.7 17.00 7.0 8.3
NEU (%) 60–77 90 86 86 80 77 67
LYM (%) 12–30 2 3 5 5 10 17
EOS (%) 2–10 4 3 4 12 8 8
RBC (M/μl) 5.5–8.5 5.2 4.53 5.5 5.5 5.2 5.6
HGB (g/dl) 12–18 10.6 9.3 11.6 11 11.4 11.8
Hct (%) 37–55 28.5 28.1 34 35.1 34.7 36
Tot. Prot. (g/dl) 5.5–7.8 3.2 (Alb 1.0) 5.8 (Alb 1.3) 4.8 (Alb 2.4) 3.6 (Alb 1.1) 3.6 (Alb 1.2) 5.6 (Alb 2.5)
Note: CRP (C reactive protein); PLT (platelet) and MONO% (% monocites) were all within normal range
Table 2 Results of faecal monitoring. Presence/absence of Strongyloides stercoralis motile larvae on 3 days faecal pools collected
directly from the dog ampullae
Faecal monitoring Dog 2 Dog 3 Dog 4 Dog 5 Dog 6
Diagnosis/Treatment start D0 Positive Positive Positive Positive Positive
Follow-up 1 Negative (D 7, 8, 9) Negative (D 6, 7, 8) Negative (D 7, 8, 9) Negative (D 10, 11, 12) Negative (D 6, 7, 8)
Follow-up 2 Negative (D 24, 25, 26) Negative (D 23, 24, 25) Negative (D 24, 25, 26) Negative (D 27, 28, 29) na
Follow-up 3 Positive (D 41, 42, 43) Negative (D 40, 41, 42) Negative (D 41, 42, 43) Negative (D 44, 45, 46) na
Follow-up 4 na Negative (D 57, 58, 59) Negative (D 58, 59, 60) na na
Abbreviations: D days post-treatment, na not available
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tapered tail and a genital tract paired with the uteri
filled with a small number of developing eggs. SEM
allowed visualisation of the cephalic region of the S.
stercoralis adult female, with its hexagonal-shaped
mouth (Fig. 3). In Dogs 2 and 5, scraping of the in-
testinal mucosa revealed the presence of few different
parasitic stages and only rare adult females, respect-
ively. Histopathological examination of Dog 1 revealed
severe hemorrhagic lymphoplasmacellular enteritis in-
volving the entire intestinal tract. Adult nematodes,
larvae and eggs (Fig. 4) were observed in the duode-
num. Furthermore, moderate interstitial pneumonia and
mild atelectasis were observed. In Dogs 2 and 5, a mild
and moderate inflammatory infiltrate in the duodenum,
mainly consisting in lymphocytes and plasma cells, re-
spectively, were the only pathological finding reported.
Migrating larvae could not be detected in viscera of any of
the dogs.
Discussion
This study documents, for the first time, the presence of
S. stercoralis infection in sheltered dogs from southern
Italy. Given the limited sensitivity of the current diag-
nostic techniques used to detect the infection, the preva-
lence of this parasite in canine populations (especially in
shelters, where the risk of transmission is higher), is
most likely underestimated. In Italy, the occurrence of S.
stercoralis in canine faecal samples had been diagnosed
Fig. 1 a, b Strongyloides stercoralis L1 rhabditiform larvae observed in fresh faecal smear following clarification in 20% lactophenol.
Scale-bars: a, 500 μm; b, 100 μm
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Fig. 2 Adult Strongyloides stercoralis female collected from a duodenal scraping. a Parasitic female in toto: oesophagus length is
appreciable. b Position of the vulva and intrauterine eggs. c Narrowly tapered tail. d Cephalic region observed under SEM. Scale-bars:
a, 500 μm; b, 50 μm; c, 50 μm; d, 5 μm
Fig. 3 Scanning electron micrograph of the cephalic region of Strongyloides stercoralis adult female; note the exagonal shape of the
mouth. Scale-bar: 2 μm
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in northern [16] and central regions [20], while a single
case report has been described in a national journal [21].
Strongyloides stercoralis infections are often asymptom-
atic in dogs; this, together with the low reliability of the
Baermann sedimentation as a gold diagnostic standard,
makes the assessment of the ‘true’ prevalence of infec-
tion challenging. The limited sensitivity of this test was
clearly indicated by the fact that, in Dog 5, no larvae
could be detected in the faecal samples collected at the
post-treatment follow-ups, whereas intestinal mucosal
scraping revealed the presence of rare adult females
(Dog 5). In addition, in Dog 3, diagnosis was achieved
following repeated testing, likely as a consequence of
low larval counts in the faecal sample or to intermittent
larval shedding, often occurring in chronic infections
[1]. In humans, false negative results could translate into
crucial (and potentially fatal) misdiagnoses, as un-
detected infections may leave the patient exposed to the
risk of developing disseminated strongyloidiasis at any
time in life [15]. Accordingly, serological testing has
been proposed to monitor the efficacy of anthelmintic
treatment in human strongyloidiasis [22]; such tests (or
similar assays, including molecular-based) would be in-
valuable for use towards the diagnosis of canine stron-
gyloidiasis in order to prevent the occurrence of false
negative results.
A thorough knowledge of the range of clinical presen-
tations of canine strongyloidiasis, together with the bio-
chemical alterations in affected dogs, is crucial in order
to consider inclusion of this infection amongst the list of
differential diagnoses in dogs with compatible signs.
While in dogs, symptomatic strongyloidiasis is often as-
sociated with young animals or puppies [5, 23], in this
study we have reported the occurrence of cases of symp-
tomatic S. stercoralis infection in adult dogs, with or
without concomitant infections. These were charac-
terised by severe clinical signs, with three deaths ob-
served; however, based solely on our observations,
neither of these deaths could be ascribed to Strongy-
loides dissemination. Indeed, Dog 1 and Dog 5 died
most likely as a result of long lasting intestinal damage,
and screening of visceral organs and tissues did not re-
veal the presence of larvae. On the other hand, while the
exact cause of death of Dog 2 could not be established,
the presence of a concomitant tumour that did not re-
spond to administration of chemotherapeutics is likely
to have contributed significantly to this outcome, simi-
larly to previous observations in humans [24]. Therefore,
based on the results in our study, the occurrence of dis-
seminated strongyloidiasis in dogs [25] could not be estab-
lished. Although none of the laboratory changes shared by
the Strongyloides-positive dogs (e.g. leukocytosis with neu-
trophilia, mild anemia, hypoalbuminemia, increase in CRP
and α2 globulin fraction) is specific for the infection, the
combination of these findings could increase the suspicion
of the disease. Conversely, eosinophilia, which is often as-
sociated with human strongyloidiasis [26], was observed
only in one dog.
Together with the low sensitivity of the diagnostic
tests currently used and the scarce information on the
clinical presentation of the disease, detection of canine
strongyloidiasis is also impaired by the challenges in dif-
ferentiating S. stercoralis larvae from larvae of free-living
nematodes, which may be present in faecal samples.
Therefore, the direct collection of faecal samples from
the rectal ampulla rather than from the environment,
and a thorough morphological discrimination of larvae
shed by other parasitic nematodes of dogs (i.e. Angios-
trongylus vasorum, Crenosoma vulpis, Oslerus osleri,
Filaroides hirti and Filaroides milksi) is warranted, and
contributes to provide a more reliable snapshot of the
distribution of this infection in canine populations.
The efficacy of a single course of treatment with
fenbendazole, associated or not with Im/Mox spot-on
was not 100% effective in eliminating the infection.
Fig. 4 Histopathology: duodenum (hematoxylin and eosin staining).
a adult Strongyloides stercoralis in the mucosa (magnification of
10 × 10). b Eggs, larvae and fragments of adults in the mucosa
(magnification of 10 × 20)
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Fenbendazole was selected based on its safety record, as
well as based on its administration route, while the asso-
ciation of Im/Mox was intended to increase the effect-
iveness against the infection. On the whole, data on the
efficacy of treatments against canine strongyloidiasis is
limited to two studies [27, 28] and single case reports
[29] or anectodal experiences. Fenbendazole was previ-
ously shown to be effective against Strongyloides in six
naturally infected dogs (out of seven) from Japan [27].
Treatment with ivermectin, i.e. the treatment of choice
in human strongyloidiasis [30], had been previously
tested in three experimentally- and two naturally in-
fected dogs [28]. One of the latter dogs suffered a recru-
descence, while treatment of experimentally infected
dogs was not effective in clearing third-stage larvae from
parenteral sites [28]. In our study, the efficacy of a single
course of treatment with fenbendazole, associated or not
with Im/Mox spot-on did not consistently result in the
elimination of the infection. It could be argued that this
outcome is related to the severity of clinical signs ob-
served at admission and that a favourable response (i.e.
no larval excretion) may still be seen in other cases, thus
highlighting the importance of a prompt diagnosis. Fur-
thermore, because of the abovementioned limitations of
the Baermann technique, faecal monitoring by molecular
tools is likely to represent a better choice when evaluat-
ing the efficacy of treatment in individual dogs.
Overall, our data indicate that S. stercoralis infection
may represent a concern for sheltered animals and point
to the potential risk of infection for personnel working
in the large number of municipal shelters [31] present in
southern European Countries (e.g. Italy, Spain, Portugal,
Greece). Indeed, limited financial resources in such con-
texts may impair the implementation of regular
deworming programs, thus increasing the risk of zoo-
notic transmission of this infection. All infected dogs de-
scribed in this study were housed in the shelter and
were neutered, thus indicating that lactogenic transmis-
sion did not play a role in the maintenance of the infec-
tion in the shelter (cf. [5]), and that this was spread via
contaminated faeces. Under these circumstances, the ap-
plication of correct deworming protocols [28] is neces-
sary to reduce the environmental infective larval burden
and, therefore, protect dogs and workers alike from the
risk of infection.
Conclusions
The study describes the occurrence of S. stercoralis in-
fection in shelter dogs from Italy. Based on our observa-
tions, we advocate for an increase awareness of this
disease, for both owners and veterinarians, and of its po-
tential zoonotic risk. Therefore, we propose that infec-
tion by S. stercoralis should be included in the list of
differential diagnoses of gastrointestinal disease. In
addition, considering that a single course of treatment
with fenbendazole, associated or not to Im/Mox spot-on
may be ineffective to eliminate the infection, control
strategies targeting the environment should be imple-
mented to reduce the risk of infection. Importantly,
monitoring programs managed by health authorities are
necessary to limit the impact of this disease on human
and canine populations alike.
Abbreviation
CRP: C reactive protein
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